Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients

Benca, 1992, Sleep and psychiatric disorders. A meta-analysis, Arch Gen Psychiatry, 49, 651, 10.1001/archpsyc.1992.01820080059010 Rush, 1986, Polysomnographic findings in recently drug-free and clinically remitted depressed patients, Arch Gen Psychiatry, 43, 878, 10.1001/archpsyc.1986.01800090068009 Armitage, 1996, Effects of antidepressant treatment on sleep EEG in depression, J Psychopharmacol, 1, 22, 10.1177/026988119601001s01 Buysse, 2001, Sleep and treatment response in depression: new findings using power spectral analysis, Psychiatry Res, 103, 51, 10.1016/S0165-1781(01)00270-0 Brunello, 2000, Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment, Neuropsychobiology, 42, 107, 10.1159/000026680 Thase, 1999, Antidepressant treatment of the depressed patient with insomnia, J Clin Psychiatry, 60, 28 Giles, 1987, Reduced rapid eye movement latency. A predictor of recurrence in depression, Neuropsychopharmacology, 1, 51, 10.1016/0893-133X(87)90007-8 Heiligenstein, 1994, Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients, Psychiatry Res, 10, 85 Sandor, 1994, Sleep patterns in depression and anxiety: theory and pharmacological effects, J Psychosom Res, 38, 125, 10.1016/0022-3999(94)90143-0 Van den Hoofdakker, 1988, On the contribution of sleep wake physiology to the explanation and the treatment of depression, Acta Psychiat Scand, S341, 53, 10.1111/j.1600-0447.1988.tb08555.x Blier, 1987, Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J Clin Psychopharmacol, 7, 24S, 10.1097/00004714-198712001-00003 Nicholson, 1988, Studies on the modulation on the sleep-wakefulness continuum in man by fluoxetine, a 5-HT uptake inhibitor, Neuropharmacology, 27, 597, 10.1016/0028-3908(88)90180-3 Yatham, 2000, Brain serotonin2 receptors in major depression, Arch Gen Psychiatry, 57, 850, 10.1001/archpsyc.57.9.850 Velázquez-Moctezuma, 1990, Microinjections of nicotine in the medial pontine reticular formation elicits REM sleep, Neurosci Lett, 115, 265, 10.1016/0304-3940(90)90466-M Gillin, 1997, A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial, J Clin Psychiatry, 58, 185, 10.4088/JCP.v58n0502 Armitage, 1997, A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients, J Clin Psychopharmacol, 17, 161, 10.1097/00004714-199706000-00004 Vogel, 1990, Drug effects on REM sleep and on endogenous depression, Neurosci Biobehav Rev, 14, 49, 10.1016/S0149-7634(05)80159-9 Armitage, 1995, Fluoxetine and oculomotor activity during sleep in depressed patients, Neuropsychopharmacology, 12, 159, 10.1038/sj.npp.1380250 Ciapparelli, 1992, The effects of fluoxetine on sleep pattern: a clinical and all-night EEG study in patients with major depression, J Sleep Res, 1, 41 Dorsey, 1996, Fluoxetine-induced sleep disturbance in depressed patients, Neuropsychopharmacology, 14, 437, 10.1016/0893-133X(95)00148-7 Hendrickse, 1994, The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study, Neuropsychopharmacology, 10, 85, 10.1038/npp.1994.10 Kerkhofs, 1990, Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables, Int Clin Psychopharmacol, 5, 252, 10.1097/00004850-199010000-00002 Trivedi, 1999, Effects of fluoxetine on the polysomnogram in outpatients with major depression, Neuropsychopharmacology, 20, 447, 10.1016/S0893-133X(98)00131-6 Gillin, 1994, Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers, J Psychopharmacol, 14, 264 Salín-Pascual, 1998, A novel effect of nicotine on mood and sleep in major depression, Neuroreport, 9, 57, 10.1097/00001756-199801050-00012 Thorsteinsson, 2001, The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression, Neuropsychopharmacology, 24, 350, 10.1016/S0893-133X(00)00217-7 Breslau, 1992, Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiological study of young adults, Am J Psychiatry, 149, 464, 10.1176/ajp.149.4.464 Salín-Pascual, 1995, Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients, Psychopharmacology, 121, 476, 10.1007/BF02246496 Pomerleau, 1992, Euphoriant effects of nicotine in smokers, Psychopharmacology, 108, 460, 10.1007/BF02247422 Rechtschaffen, 1968 Rioux, 1996, A double-blind comparison of nefazodone and fluoxetine in depressed patients, Am J Psychiatry, 153, 164 Rush, 1998, Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder, Biol Psychiatry, 44, 3, 10.1016/S0006-3223(98)00092-4 Mihailescu, 2000, Nicotine, brain nicotinic receptors, and neuropsychiatric disorders, Arch Med Res, 31, 131, 10.1016/S0188-4409(99)00087-9 Mihailescu, 2001, Nicotine stimulation of dorsal raphe neurons: effects on laterodorsal and pedunculopontine neurons, Eur Neuropsychopharmacol, 11, 359, 10.1016/S0924-977X(01)00104-3 Vázquez, 1996, Transdermal nicotine on sleep and PGO spikes, Brain Res, 737, 317, 10.1016/0006-8993(96)00921-3 Mihailescu, 1998, Effects of nicotine and mecamylamine on rat dorsal raphe neurons, Eur J Pharmacol, 360, 31, 10.1016/S0014-2999(98)00658-X Knowles, 1982, Definitions of REM latency: some comparisons with particular reference to depression, Biol Psychiatry, 17, 993 Coble, 1981, Distribution of REM latency in depression, Biol Psychiatry, 16, 453 Marks, 1983, Effects of chronic nicotine infusion on tolerance development and cholinergic receptors, J Pharmacol Excerpt Ther, 226, 806 Marks, 1992, Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment, J Neurosci, 12, 2765, 10.1523/JNEUROSCI.12-07-02765.1992 Guzmán-Marín, 2001, Subcutaneous administration of nicotine changes dorsal raphe serotonergic neurons discharge rate during REM sleep, Brain Res, 888, 321, 10.1016/S0006-8993(00)03104-8 Keck, 1991, Effects of fluoxetine on sleep, Biol Psychiatry, 29, 618, 10.1016/0006-3223(91)90097-6 Saletu, 1991, Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities, Sleep, 14, 439, 10.1093/sleep/14.5.439 Saletu, 1985, Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetics, pharmaco-EEG and psychometric analyses, J Clin Psychiatry, 46, 45 von Bardeleben, 1989, Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls, Int Clin Psychopharmacol, 4, 1 Lemberger, 1985, Fluoxetine: clinical pharmacology and physiological disposition, J Clin Psychiatry, 46, 14 Stark, 1985, The pharmacologic profile of fluoxetine, J Clin Psychiatry, 46, 7 Winkler, 2002, Maintenance treatment in depression: the role of pharmacological and psychological treatment, Curr Opin Psychiatry, 15, 63, 10.1097/00001504-200201000-00011 Meyer, 2001, Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C] DASB PET imaging study, Am J Psychiatry, 158, 1843, 10.1176/appi.ajp.158.11.1843